Altretamine

This classification denotes an ethylenimine compound with the molecular formula C9H18N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q8BIH59O7H, chemically known as 2,4,6-tris(dimethylamino)-s-triazine but more generally known as altretamine, which bears US NIH Compound Identifier 2123. European Medicines Agency schedules Altretamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05382MIG. The term ALTRETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules altretamine in its Anatomical Therapeutic Chemical (ATC) Classification. ALTRETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule altretamine under HS 29336980 and SITC 51576. As of Q4 2014, ALTRETAMINE remains US FDA's Preferred Term for this commodity. Altretamine bears US NLM identifiers UMLS ID C0019453 and NCI Concept Code C544. SMILES: N(C1NC(N(C)C)NC(N(C)C)N1)(C)C.